Cargando…

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

BACKGROUND: Evaluation of cardiovascular prognosis in patients with stable coronary heart disease is based on clinical characteristics and biomarkers indicating dysglycemia, dyslipidemia, renal dysfunction, and possibly cardiac dysfunction. Inflammation plays a key role in atherosclerosis, but the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Held, Claes, White, Harvey D., Stewart, Ralph A. H., Budaj, Andrzej, Cannon, Christopher P., Hochman, Judith S., Koenig, Wolfgang, Siegbahn, Agneta, Steg, Philippe Gabriel, Soffer, Joseph, Weaver, W. Douglas, Östlund, Ollie, Wallentin, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721818/ https://www.ncbi.nlm.nih.gov/pubmed/29066452 http://dx.doi.org/10.1161/JAHA.116.005077

Ejemplares similares

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
por: Guimarães, Patricia Oliveira, et al.
Publicado: (2017)

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
por: Fanola, Christina L., et al.
Publicado: (2017)

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
por: Held, Claes, et al.
Publicado: (2022)

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
por: Hilvo, Mika, et al.
Publicado: (2020)

LncRNAs as Regulators of Atherosclerotic Plaque Stability
por: Petkovic, Aleksa, et al.
Publicado: (2023)

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial
por: Eisen, Alon, et al.
Publicado: (2017)

Stability Analysis of a Model of Atherosclerotic Plaque Growth
por: Reddy, Sushruth, et al.
Publicado: (2015)

Restoration of normal blood flow in atherosclerotic arteries promotes plaque stabilization
por: Schake, Morgan A., et al.
Publicado: (2023)

Physical activity in patients with stable coronary heart disease: an international perspective
por: Stewart, Ralph, et al.
Publicado: (2013)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

Direct association between diet and the stability of human atherosclerotic plaque
por: Gonçalves, Isabel, et al.
Publicado: (2015)

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
por: Baardman, Jeroen, et al.
Publicado: (2020)

Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque
por: Kowara, Michal, et al.
Publicado: (2021)

Desipramine enhances the stability of atherosclerotic plaque in rabbits monitored with molecular imaging
por: Zhao, Min, et al.
Publicado: (2023)

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial
por: Johnson, Joel L., et al.
Publicado: (2014)

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: Åkerblom, Axel, et al.
Publicado: (2019)

Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization
por: van Ingen, Eva, et al.
Publicado: (2019)

Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
por: Segers, Dolf, et al.
Publicado: (2011)

Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties
por: Wang, Shuang-shuang, et al.
Publicado: (2015)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
por: Preusch, Michael R, et al.
Publicado: (2016)

Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis
por: Konishi, Takao, et al.
Publicado: (2018)

Impact of Fiber Structure on the Material Stability and Rupture Mechanisms of Coronary Atherosclerotic Plaques
por: Douglas, Graeham R., et al.
Publicado: (2017)

Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques
por: Zhou, Jia, et al.
Publicado: (2022)

Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque
por: Chen, Weiyu, et al.
Publicado: (2022)

DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
por: Herman, Allison B., et al.
Publicado: (2023)

Potential new therapeutic targets: Association of microRNA with atherosclerotic plaque stability
por: Huang, Pan
Publicado: (2023)

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
por: Batra, Gorav, et al.
Publicado: (2022)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib
por: Yeo, Astrid, et al.
Publicado: (2017)

A numerical study of the effect of varied blood pressure on the stability of carotid atherosclerotic plaque
por: Xiong, Huahua, et al.
Publicado: (2014)

Tongxinluo May Alleviate Inflammation and Improve the Stability of Atherosclerotic Plaques by Changing the Intestinal Flora
por: Qi, Yan, et al.
Publicado: (2022)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
por: Stewart, Ralph A. H., et al.
Publicado: (2017)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019)

Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
por: GUO, SUXIA, et al.
Publicado: (2012)

Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms
por: Tian, Yuling, et al.
Publicado: (2017)

Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype
por: Zhang, Xue, et al.
Publicado: (2017)

Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
por: Ruddy, Jean Marie, et al.
Publicado: (2016)

Therapeutic ultrasound combined with microbubbles improves atherosclerotic plaque stability by selectively destroying the intraplaque neovasculature
por: Li, Xinzhong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9h9ita87hem5gau6l5ouf0p7f8